Zafgen is a cutting-edge biopharmaceutical company committed to tackling the growing epidemic of obesity and other metabolic disorders. Their mission is to improve the lives of patients through innovative solutions that address the root causes of these conditions. With a focus on groundbreaking research and development, Zafgen is poised to lead the field in the fight against obesity and related health problems. Investors and stakeholders alike are keeping a close eye on the company's progress and potential for growth in the coming years.